Neuralstem Inc is an biotechnology company which is engaged on developing and commercializing human neural stem cell technology in the emerging field of regenerative medicine.


Updates from The Motley Fool

Latest updates on Neuralstem from Fool.com.
3 Biotech Stocks to Buy in March

Our experts weigh in on why they like Vertex Pharmaceuticals, Neuralstem, and Intercept Pharmaceu...

Why Neuralstem Inc. Shares Soared

Neuralstem shares jumped after reporting another positive study involving its lead pipeline produ...

This Week in Biotech

A look back at the biggest stories this week in biotech and what they mean for investors.



Stock Performance

View Interactive CUR Charts
Sponsored by

Key Data Points

Primary metrics and data points about Neuralstem.
Current Price: $1.40
Prev Close: $1.42
Open: $1.45
Bid: $1.41
Ask: $1.42
Day's Range: $1.39 - $1.53
52wk Range: $0.99 - $6.60
Volume: 657,873
Avg Vol 741,448
Market Cap: $21M
P/E (ttm): -0.64
EPS (ttm): ($2.22)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Neuralstem.
CAPS Rating 1 out of 5
 
82 Outperform
18 Underperform
CAPS All Stars
 
7 Outperform
10 Underperform

How do you think Neuralstem will perform against the market?



You pick for Neuralstem is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Neuralstem.

Neuralstem Inc is an biotechnology company which is engaged on developing and commercializing human neural stem cell technology in the emerging field of regenerative medicine.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers